AKE Arkema S.A.

61.09USD55.70 EUR · EPA-2.79%Mkt Cap: 4.67B USDP/E: 222.80

Arkema S.A., together with its subsidiaries, manufactures and sells specialty materials in Europe, the United States, Canada, Mexico, China, Hong Kong, Taiwan, and internationally. It operates in three segments: Adhesive…

Institutional holders11 on file

Key Statistics

Company
Market Cap4.67B USD
Enterprise Value7.84B USD
Revenue (TTM)9.96B USD
Gross Profit1.77B USD
Net Income (TTM)69.10M USD
Revenue/Share131.71 USD
Last Price61.09 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees20.7K
CountryFR
SectorBasic Materials
IndustrySpecialty Chemicals
ISINFR0010313833
Valuation
P/E (Trailing)222.80
P/E (Forward)11.31
PEG0.42
EV/EBITDA6.19
EV/Revenue0.79
P/S0.47
P/B0.68
EPS (TTM)0.27 USD
EPS (Forward)5.40 USD
52W Range
52.9839% of range73.54
52W High73.54 USD
52W Low52.98 USD
Profitability
Gross Margin17.80%
Oper. Margin4.56%
EBITDA Margin12.71%
Profit Margin0.69%
ROE0.92%
ROA0.44%
ROIC2.23%
ROCE3.50%
Growth
Revenue Growth8.10%
Earnings Growth68.90%
Cash Flow & Leverage
Operating CF1.09B USD
CapEx (TTM)723.89M USD
FCF Margin4.58%
FCF Yield9.76%
Net Debt2.98B USD
Net Debt/EBITDA2.35
Net Debt/FCF6.52
Balance Sheet
Debt/Equity0.67
Current Ratio1.59
Quick Ratio1.10
Book Value/Sh89.19 USD
Cash/Share22.27 USD
Dividends
Fwd Div Rate3.95 USD
Trail. Div Rate3.95 USD
Div. Yield6.23%
5Y Avg Yield3.92%
Payout Ratio1440.00%
Ex-Div DateMay 25, 2026
Pay Date—
Analyst Consensus
Rating2.6 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)68.98 USD
Upside (mean)+12.9%
Target Range54.84 USD – 87.74 USD
54.84+12.9% to mean87.74
# Analysts14
Ownership
Shares Out.76.51M
Float56.77M
Insiders10.18%
Institutions59.55%
Technical
SMA 5061.74 (-1.1%)
SMA 20063.94 (-4.5%)
Beta1.00
S&P 52W Chg12.00%
Avg Vol (30d)163.58K
Avg Vol (10d)160.42K
Technical Indicators
RSI (14)42.1
MACD0.3639
MACD Signal0.4844
MACD Hist.-0.1205
BB Upper65.57 USD
BB Middle62.46 USD
BB Lower59.35 USD
BB Width9.95%
ATR (14)1.258 USD
Vol Ratio (20d)1.09x

About Arkema (EPA: AKE)

›

Arkema (EPA: AKE) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Specialty Chemicals industry, part of the Basic Materials sector, and reports about 20,700 employees.

The shares were at 55.70 EUR on 19 November 2026, up 9.5% over 52 weeks. Its 52-week range is 48.30 EUR to 67.05 EUR: the price is 16.9% below the high and 15.3% above the low.

At a market capitalisation of 4.26B EUR, it trades at 222.8 times trailing earnings and 11.3 times forward earnings. The median trailing P/E of its 18 largest Specialty Chemicals peers is 34.0, a premium of 556% for AKE. It pays a dividend yielding 6.23%, against a median of 1.76% among the dividend payers in that peer group.

Arkema reports return on equity of 0.9%, an operating margin of 4.6% and revenue up 8.1% year over year.

Its debt exceeds its cash by 2.71B EUR, a debt-to-equity ratio of 0.67. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 14 analysts cover the stock, with an average rating of Hold; their mean price target of 62.89 EUR is 12.9% above the current price. The next earnings report is expected on 25 February 2027.